Research Transparency Panel Meeting Summary
Flatiron, on behalf of Johnson & Johnson
3rd December 2024
Data Access Proposal Request
Flatiron Health UK RWD Products
-
Non-small cell lung cancer
Attendees
Flatiron Health UK
-
Adam Manhi (chair)
-
Emma Salib (programme manager)
Research Transparency Panel
-
Jennifer McCaffery (lay)
-
Hayley Hall (lay)
-
Sonia Patton (patient)
-
Trishna Bharadia (patient)
-
Yanrong Jiang (clinical)
Conflicts of interest
No conflicts declared by panel
Decision outcome
Approved
Summary of discussion
-
Lay summary provides strong explanation of disease background and unmet need.
-
Good and concise description of data that will be analysed, type of analysis, objectives and outputs.
-
Clear distinction between this data access request (fit-for-purpose assessment) and potential downstream analyses to support a wider set of use cases.
-
Clear that J&J will only receive outputs of Flatiron’s analysis and no access to data.
-
The panel raised several comments on other aspects of the application including:
-
The content could have been written in more lay terms.
-
Further detail could have been provided on what patient demographic and clinical characteristics would be analysed.
-
Overall the panel felt this approach of assessing the database was likely to lead to a more focused future data access request from J&J.
-